These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 6112196)

  • 1. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation.
    Mueller H; Ayres SM
    Postgrad Med J; 1976; 52 Suppl 4():141-8. PubMed ID: 967769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions during and after acute myocardial infarction.
    Sleight P
    Postgrad Med J; 1983; 59 Suppl 3():80-8. PubMed ID: 6139802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade in acute myocardial infarction.
    Cruickshank JM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S59-70. PubMed ID: 2468837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
    Zhu BQ; Simonis U; Cecchini G; Zhou HZ; Li L; Teerlink JR; Karliner JS
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):119-28. PubMed ID: 16891289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH
    Circulation; 1983 Jun; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-receptor blockader therapy in the acute stage of myocardial infarct pathophysiological basis].
    Jentsch G
    Z Gesamte Inn Med; 1981 Jun; 36(12):401-7. PubMed ID: 6117991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial infarction size: measurement and modification.
    Cairns JA
    Can Med Assoc J; 1977 Aug; 117(3):255-62. PubMed ID: 69481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there still a role for treatment with beta-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?
    Horowitz JD; Arstall MA; Zeitz CJ; Beltrame JF
    Acute Card Care; 2008; 10(3):144-7. PubMed ID: 18608034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)].
    Lehmann HU; Oeff M; Witt E; Hochrein H
    Z Kardiol; 1981 Oct; 70(10):748-53. PubMed ID: 6795841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rest and the acutely ischaemic heart.
    Norris RM
    N Z Med J; 1980 Jul; 92(664):53-6. PubMed ID: 6107887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.